2nd Nov 2021 17:11
Sensyne Health PLC - Oxford-based healthcare technology company - Chief Executive Officer and largest shareholder Paul Drayson has requested approval from the board to speak to potential investors to pursue a management buyout of the company.
Appoints JP Morgan Cazemove and Peel Hunt to consider a management buyout proposal, and explore other buyer interest and other strategic options, including a strategic investment or pursuing a secondary US listing.
"Sensyne has initiated a formal sale process as we believe it will help the company to deliver maximum value to all shareholders and prosper in the long-term. The board is fully aligned with Drayson's proposal to explore a management buy-out as one route towards maximising value for all stakeholders while respecting our heritage and unique, ethical business model. We recognise Paul's continued motivation and commitment towards the success of the business," says Chair Bruce Keogh.
Current stock price: 100.50 pence, up 6.9% on Tuesday
Year-to-date change: down 11%
By Dayo Laniyan; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
SENS.L